Nurix Therapeutics Inc. logo

Nurix Therapeutics Inc.

NRIX | NASDAQ
Chart Builder DCF Calculator
$25.41
-$0.03 (-0.12%)
At close: Sep 21, 2026, 4:00 PM ET
$25.40
-$0.01 (-0.04%)
Pre-market: Sep 22, 2026, 5:28 AM ET
Fiscal Year
Period Ending
FY 2025
Nov 29, 2025
FY 2024
Nov 29, 2024
FY 2023
Nov 29, 2023
FY 2022
Nov 29, 2022
FY 2021
Nov 29, 2021
FY 2020
Nov 29, 2020
Cash & Equivalents
246.96M 110M 54.63M 64.47M 80.51M 119.36M
Short-Term Investments
345.98M 499.59M 233.28M 244.67M 215.21M 161.79M
Long-Term Investments
n/a n/a 7.42M 63.88M 137.48M 90.89M
Other Long-Term Assets
8.31M 4.06M 4.72M 4.92M 3.12M 347K
Receivables
n/a 1.5M 800K 1.1M 6.2M 11.35M
Inventory
n/a n/a n/a -1.1M n/a n/a
Other Current Assets
13.88M 8.3M 6.8M 9.31M 900K n/a
Total Current Assets
606.82M 619.39M 295.5M 318.45M 311.12M 298.43M
Property-Plant & Equipment
73.01M 45.9M 47.95M 29.51M 25.35M 6.67M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
81.32M 49.96M 60.1M 98.31M 165.65M 97.91M
Total Assets
688.14M 669.34M 355.6M 416.76M 476.77M 396.34M
Account Payables
11.22M 11.48M 6.4M 5.06M 6.65M 3.41M
Deferred Revenue
17.58M 38.36M 48.1M 37.63M 41.21M 32.8M
Short-Term Debt
n/a n/a 7.49M 5.53M 3.85M n/a
Other Current Liabilities
23.64M 18.91M 751K 9.14M 5.67M 2.6M
Total Current Liabilities
86.47M 95.85M 86.96M 70.66M 66.26M 44.54M
Long-Term Debt
n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a 850K
Total Long-Term Liabilities
62.92M 46.5M 68.15M 42.41M 68.21M 61.54M
Total Liabilities
149.39M 142.35M 155.11M 113.06M 134.47M 106.07M
Total Debt
55.73M 28.3M 30.61M 11.96M 13.04M n/a
Book Value
538.75M 526.99M 200.49M 303.7M 342.3M 290.27M
Book Value Per Share
6.22 7.85 3.69 6.25 7.98 18.52
Common Stock
102K 76K 49K 47K 45K 39K
Retained Earnings
-1B -738.77M -545.2M -401.25M -220.89M -103.7M
Comprehensive Income
105K 150K -655K -4.32M -608K 87K
Shareholders Equity
538.75M 526.99M 200.49M 303.7M 342.3M 290.27M
Total Investments
345.98M 499.59M 240.7M 308.55M 352.4M 252.68M

© 2026 bestshares.com. All rights reserved.